IP Verse

Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding Reagents - EP2956483

PATENT ANALYSIS

Patent Details

Grant Date
May 27, 2020
Company
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Oppositions

CHUGAI SEIYAKU KABUSHIKI KAISHA

DR. H. ULRICH DORRIES

JAMES POOLE LIMITED

More patents of Boehringer Ingelheim International Gmbh

EP2313087

EP3110449

EP3802922

Want to monitor this patent?

Feel free to send us a message here and we will get back to you